Chemung Financial (CMHG) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
7 Aug, 2025Executive summary
Reported a net loss of $6.5M for Q2 2025, driven by a $17.5M loss on securities sales, offset by a $0.6M gain on branch property sale.
Excluding nonrecurring items, adjusted net income was $6.3M for Q2 2025, up 26.8% year-over-year, reflecting solid core operating results.
Issued $45M in subordinated debt and sold $245.5M in securities to strengthen capital and fund loan growth.
Wealth Management Group assets under management increased 4.5% since year-end 2024, reflecting market improvements.
Financial highlights
Net interest income for Q2 2025 was $20.8M, up 17.2% year-over-year; net interest margin rose to 3.05%.
Non-interest income was a loss of $10.7M, mainly due to the $17.5M securities sale loss.
Non-interest expense increased 9.9% year-over-year to $17.8M, driven by higher compensation and professional services.
Allowance for credit losses increased to $22.7M, or 1.06% of total loans.
Total assets grew 2.7% since year-end to $2.85B; loans rose 2.9% to $2.13B; deposits up 3.0% to $2.47B.
Outlook and guidance
Management expects proceeds from securities sales and subordinated debt to fund future organic loan growth and lower funding costs.
Anticipates continued focus on commercial lending, especially in key expansion markets.
Ongoing monitoring of economic conditions and credit quality, with allowance for credit losses sensitive to macroeconomic forecasts.
Management remains optimistic about core operating performance and principal initiatives.
Latest events from Chemung Financial
- All proposals passed; strong 2023 results, expansion, and dividends highlighted.CMHG
AGM 202431 Jan 2026 - Annual non-GAAP net income rose 17.8% to $27.9M, driven by strong loan growth and margin gains.CMHG
Q4 202526 Jan 2026 - Board recommends FOR all proposals, including director elections and new equity plan.CMHG
Proxy Filing2 Dec 2025 - Virtual meeting to elect directors, approve pay, equity plan, and auditor ratification.CMHG
Proxy Filing2 Dec 2025 - All proposals, including director elections and compensation, were approved by majority vote.CMHG
AGM 202526 Nov 2025 - Q3 net income up 36% year-over-year, with strong loan growth and improved margins.CMHG
Q3 20256 Nov 2025 - Net income declined 21% year-over-year as margin pressure persisted, but capital and lending improved.CMHG
Q2 20249 Oct 2025 - Q3 2024 net income fell year-over-year as higher costs offset loan growth and margin stability.CMHG
Q3 202413 Jun 2025 - 2024 net income fell 5.3% to $23.7M as higher expenses offset loan growth.CMHG
Q4 20249 Jun 2025